Head-to-head · computed 2026-08-11
Direct Meds vs Gala GLP-1
Direct Meds: Direct Meds offers compounded GLP-1s in multiple formats — sublingual and injectable — with all-inclusive pricing verified on its own product pages. Semaglutide runs $249–$297/mo and tirzepatide $299–$399/mo depending on format; the lower figures are for sublingual delivery. Gala GLP-1: Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149.
Tirzepatide
| Direct Meds | Gala GLP-1 | |
|---|---|---|
| All-in maintenance | $399/mo | $179/mo |
| Best plan rate | $399/mo | $179/mo |
| 12-month total | $4,788 | $2,148 |
| Status | Reported · 2026-07-25 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, Gala GLP-1's $179 a month undercuts Direct Meds's $399 by $220 a month at the 10 mg/wk maintenance basis — $2,640 across a year. Gala GLP-1's figure is reported (captured 2026-07-14) and Direct Meds's is reported (captured 2026-07-25); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Direct Meds's tirzepatide ladder runs $399 a month billed monthly. Gala GLP-1's runs $179 a month billed monthly, and $199 a month on a three-month plan. On the twelve-month basis Gala GLP-1's $2,148 beats Direct Meds's $4,788 by $2,640 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| Direct Meds | Gala GLP-1 | |
|---|---|---|
| All-in maintenance | $297/mo | $179/mo |
| Best plan rate | $297/mo | $179/mo |
| 12-month total | $3,564 | $2,148 |
| Status | Reported · 2026-07-25 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, Gala GLP-1's $179 a month undercuts Direct Meds's $297 by $118 a month at the 2.4 mg/wk maintenance basis — $1,416 across a year. Gala GLP-1's figure is reported (captured 2026-07-14) and Direct Meds's is reported (captured 2026-07-25); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Direct Meds's semaglutide ladder runs $297 a month billed monthly. Gala GLP-1's runs $179 a month billed monthly, and $199 a month on a three-month plan. On the twelve-month basis Gala GLP-1's $2,148 beats Direct Meds's $3,564 by $1,416 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Where the structures genuinely differ
On dose economics, Gala GLP-1 is dose-flat — the price survives titration — while Direct Meds's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses.
Structure, side by side
Direct Meds
- MembershipNone
- Dose policyAll-inclusive per format; injection and sublingual priced separately
- CommitmentMonthly (no commitment indicated)
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
Gala GLP-1
- MembershipNone
- Dose policyFlat at 'all doses' for standard plan; separate microdosing tier at $149
- Commitment3-month plan or standard monthly; confirm exact terms at enrollment
- CancellationPer provider terms
- PharmacyPartner 503A pharmacies (not named publicly)
What our desk is watching on each
Direct Meds: Pricing varies by format and page; product-page 'all-inclusive' rates differ from homepage promo cards. Rank is based on injectable rate as primary. Reported status — RangeYourself verified 2026-07-25 on Direct Meds' own product pages.
Gala GLP-1: Gala lists a range rather than one fixed price: the hero says $179/mo 'all doses', the FAQ says $199/mo 'with a 3-month plan', and $149/mo is listed for microdosing. This makes 'all-in maintenance' ambiguous; we rank on the $179 standard figure with a note. Exact ongoing rate must be confirmed at enrollment. Reported status from RangeYourself 2026-07-14.
Questions people ask
Is Direct Meds or Gala GLP-1 cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Direct Meds vs Gala GLP-1 miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Direct Meds and Gala GLP-1 cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $4,788 at Direct Meds and $2,148 at Gala GLP-1 — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Direct Meds · Gala GLP-1. Official sites: Direct Meds ↗ · Gala GLP-1 ↗. Nothing here is medical advice.